Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Caraceni, Paolo; De Ponti, Fabrizio, Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database, «WORLD JOURNAL OF HEPATOLOGY», 2014, 6, pp. 601 - 612 [articolo]
Raschi, Emanuel; De Ponti, Fabrizio, Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2014, 10, pp. 293 - 305 [articolo]
Salvo, Francesco; Raschi, Emanuel; Moretti, Ugo; Chiarolanza, Anita; Fourrier-Réglat, Annie; Moore, Nicholas; Sturkemboom, Miriam; De Ponti, Fabrizio; Poluzzi, Elisabetta; Pariente, Antoine, Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2014, 70, pp. 617 - 625 [articolo]
Poluzzi, Elisabetta; Piccinni, Carlo; Raschi, Emanuel; Rampa, Angela; Recanatini, Maurizio; De Ponti, Fabrizio, Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective, «CURRENT MEDICINAL CHEMISTRY», 2014, 21, pp. 417 - 436 [articolo]
Girardi, Anna; Piccinni, Carlo; Raschi, Emanuel; Koci, Ariola; Vitamia, Benedetta; Poluzzi, Elisabetta; De Ponti, Fabrizio, Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey, «BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE», 2014, 14, Article number: 262, pp. 1 - 5 [articolo]
Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti, Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues, «PHARMACOLOGY & THERAPEUTICS», 2013, 139, pp. 71 - 86 [articolo]
Poluzzi E;Raschi E;Koci A;Moretti U;Spina E;Behr ER;Sturkenboom M;De Ponti F, Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database., «DRUG SAFETY», 2013, 36, pp. 467 - 479 [articolo]
Carlo Piccinni;Chiara Sacripanti;Elisabetta Poluzzi;Fabrizio De Ponti, Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2013, 22, pp. 443 - 445 [articolo]
De Ponti F, Drug development for the irritable bowel syndrome: current challenges and future perspectives., «FRONTIERS IN PHARMACOLOGY», 2013, 4, Article number: 7, pp. 1 - 12 [articolo]Open Access
Fabrizio De Ponti, Global Perspectives in Pharmacovigilance, «JOURNAL OF PHARMACOVIGILANCE», 2013, 01, pp. 1 - 2 [replica/breve intervento]
Emanuel Raschi; Elisabetta Poluzzi; Ariola Koci; Ugo Moretti; Miriam Sturkenboom; Fabrizio De Ponti, Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database, «JOURNAL OF PHARMACOVIGILANCE», 2013, 01, pp. 1 - 4 [articolo]
Raschi E.; Piccinni C.; Poluzzi E.; Marchesini G.; De Ponti F., The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database., «ACTA DIABETOLOGICA», 2013, 50, pp. 569 - 577 [articolo]
Raschi E;Poluzzi E;Godman B;Koci A;Moretti U;Kalaba M;Bennie M;Barbui C;Wettermark B;Sturkenboom M;De Ponti F, Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., «PLOS ONE», 2013, 8, pp. 1 - 14 [articolo]Open Access
Poluzzi E; Piccinni C; Sangiorgi E; Clo M; Tarricone I; Menchetti M; De Ponti F, Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 2095 - 2101 [articolo]
Piccinni C; Raschi E; Poluzzi E; Puccini A; Cars T; Wettermark B; Diemberger I; Boriani G; De Ponti F., Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden., «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2013, 69, pp. 715 - 720 [articolo]
